Cancer Drugs Fund


The National Audit Office has published the findings from its Investigation into the Cancer Drugs Fund. The government set up the Fund in 2010 to improve access to cancer drugs that would not otherwise be routinely available on the NHS. The key findings of this investigation include: the Fund has improved access to cancer drugs not routinely available on the NHS; 51% of the patients supported by the Fund between April 2013 and March 2015 accessed drugs that were appraised by NICE but not recommended for routine NHS commissioning; due to a lack of data, it is not possible to evaluate the impact that the Fund has had on patient outcomes, such as survival; NHS England has taken action to control the rapid growth of the cost of the Fund, including removing drugs on the grounds of cost; and all parties agree that the Fund is not sustainable in its current form.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s